Home
>
US Stocks
>
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc
TARS

Tarsus Pharmaceuticals Inc

$28.5419.16%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
28.7
Today Low/High
28.54 / 29.22
52 Week Low/High
$15.32 / $63.69
Market Cap
$511.47M

Company Details

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address a number of diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 for the treatment of Demodex blepharitis. TP-03 is also being developed for the treatment of Meibomian Gland Disease.
Organisation
Tarsus Pharmaceuticals Inc
Employees
20
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Tarsus Pharmaceuticals Inc share price today

Can Indians buy Tarsus Pharmaceuticals Inc shares?

How can I buy Tarsus Pharmaceuticals Inc shares from India?

Can Fractional shares of Tarsus Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Tarsus Pharmaceuticals Inc stocks?

We are a SEBI registered investement advisor